Back to Search Start Over

Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels

Authors :
Sassi, Atfa
Lazaroski, Sandra
Wu, Gang
Haslam, Stuart M.
Fliegauf, Manfred
Mellouli, Fethi
Patiroglu, Turkan
Unal, Ekrem
Ozdemir, Mehmet Akif
Jouhadi, Zineb
Khadir, Khadija
Ben-Khemis, Leila
Ben-Ali, Meriem
Ben-Mustapha, Imen
Borchani, Lamia H.
Pfeifer, Dietmar
Jakob, Thilo
Khemiri, Monia
Asplund, A. Charlotta
Gustafsson, Manuela O.
Lundin, Karin E.
Falk-Sörqvist, Elin
Moens, Lotte N.
Gungor, Hatice Eke
Engelhardt, Karin R.
Dziadzio, Magdalena
Stauss, Hans
Fleckenstein, Bernhard
Meier, Rebecca
Prayitno, Khairunnadiya
Maul-Pavicic, Andrea
Schaffer, Sandra
Rakhmanov, Mirzokhid
Henneke, Philipp
Kraus, Helene
Eibel, Hermann
Koelsch, Uwe
Nadifi, Sellama
Nilsson, Mats
Bejaoui, Mohamed
Schaeffer, Alejandro A.
Smith, C. I. Edvard
Dell, Anne
Barbouche, Mohamed-Ridha
Grimbacher, Bodo
Sassi, Atfa
Lazaroski, Sandra
Wu, Gang
Haslam, Stuart M.
Fliegauf, Manfred
Mellouli, Fethi
Patiroglu, Turkan
Unal, Ekrem
Ozdemir, Mehmet Akif
Jouhadi, Zineb
Khadir, Khadija
Ben-Khemis, Leila
Ben-Ali, Meriem
Ben-Mustapha, Imen
Borchani, Lamia H.
Pfeifer, Dietmar
Jakob, Thilo
Khemiri, Monia
Asplund, A. Charlotta
Gustafsson, Manuela O.
Lundin, Karin E.
Falk-Sörqvist, Elin
Moens, Lotte N.
Gungor, Hatice Eke
Engelhardt, Karin R.
Dziadzio, Magdalena
Stauss, Hans
Fleckenstein, Bernhard
Meier, Rebecca
Prayitno, Khairunnadiya
Maul-Pavicic, Andrea
Schaffer, Sandra
Rakhmanov, Mirzokhid
Henneke, Philipp
Kraus, Helene
Eibel, Hermann
Koelsch, Uwe
Nadifi, Sellama
Nilsson, Mats
Bejaoui, Mohamed
Schaeffer, Alejandro A.
Smith, C. I. Edvard
Dell, Anne
Barbouche, Mohamed-Ridha
Grimbacher, Bodo
Publication Year :
2014

Abstract

Background: Recurrent bacterial and fungal infections, eczema, and increased serum IgE levels characterize patients with the hyper-IgE syndrome (HIES). Known genetic causes for HIES are mutations in signal transducer and activator of transcription 3 (STAT3) and dedicator of cytokinesis 8 (DOCK8), which are involved in signal transduction pathways. However, glycosylation defects have not been described in patients with HIES. One crucial enzyme in the glycosylation pathway is phosphoglucomutase 3 (PGM3), which catalyzes a key step in the synthesis of uridine diphosphate N-acetylglucosamine, which is required for the biosynthesis of N-glycans. Objective: We sought to elucidate the genetic cause in patients with HIES who do not carry mutations in STAT3 or DOCK8. Methods: After establishing a linkage interval by means of SNPchip genotyping and homozygosity mapping in 2 families with HIES from Tunisia, mutational analysis was performed with selector-based, high-throughput sequencing. Protein expression was analyzed by means of Western blotting, and glycosylation was profiled by using mass spectrometry. Results: Mutational analysis of candidate genes in an 11.9-Mb linkage region on chromosome 6 shared by 2 multiplex families identified 2 homozygous mutations in PGM3 that segregated with disease status and followed recessive inheritance. The mutations predict amino acid changes in PGM3 (p. Glu340del and p. Leu83Ser). A third homozygous mutation (p. Asp502Tyr) and the p. Leu83Ser variant were identified in 2 other affected families, respectively. These hypomorphic mutations have an effect on the biosynthetic reactions involving uridine diphosphate N-acetylglucosamine. Glycomic analysis revealed an aberrant glycosylation pattern in leukocytes demonstrated by a reduced level of tri-antennary and tetra-antennary N-glycans. T-cell proliferation and differentiation were impaired in patients. Most patients had developmental delay, and many had psychomotor retardation. Conclusion

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1235142176
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1016.j.jaci.2014.02.025